Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Mi QUIT CARE(Mile Square QUIT 社区-访问-推荐-扩展)

基本信息

  • 批准号:
    10254227
  • 负责人:
  • 金额:
    $ 123.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-10 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Abstract Demonstrating the feasibility, effectiveness, and cost-effectiveness of electronically delivered smoking cessation interventions via patient portals in Federally Qualified Health Care (FQHC) settings has the potential for wide-spread dissemination and significant public health impact. on patient populations with demonstrated high rates of smoking. The specific aims of are to: UG3: Aim 1. Examine the burden of tobacco use and its influence on pulmonary health disparities (lung cancer, COPD, and asthma) in the patient population and the economically disadvantaged and racially segregated catchment areas of Mile Square Health Centers. Aim 2: Evaluate knowledge, attitudes, barriers and facilitators to: smoking cessation, engagement with the tobacco quit line, linkage to the tobacco quit line via a patient health portal and receipt of patient navigation to facilitate access to the tobacco quit line among MSHC patients and health care providers.. Aim 3: Evaluate the use of community engagement strategies to increase uptake of the UI Health Patient Portal among low-income patients receiving care at Mile Square Health Center. Aim 4: Test the acceptability, feasibility, and capacity of Mile Square Health to deliver Mi Quit CARE, an evidence-based and multi-level intervention to increase engagement with the quit line via the UI Health Portal. UH3: Aim 1: Determine the effectiveness Mi Quit CARE compared to standard of care in increasing patient engagement with the Illinois tobacco quitline and subsequent smoking cessation outcomes. Aim 2: Evaluate the scalability of Mi Quit CARE to multiple sites within the UI Health FQHC Mile Square clinic network and by translating the intervention to Spanish. Aim 3: Examine the cost effectiveness of Mi Quit CARE on smoking cessation outcomes compared to standard of care among a high risk FQHC population.
摘要 展示电子吸烟的可行性、有效性和成本效益 通过联邦合格医疗保健(FQHC)环境中的患者门户进行戒烟干预具有潜力 广泛传播和重大公共卫生影响。患者人群中, 吸烟率高。其具体目标是: UG3:目标1。检查烟草使用的负担及其对肺部健康差异的影响(肺 癌症,COPD和哮喘)的患者人群和经济上处于不利地位的人, Mile Square健康中心的隔离集水区。 目标2:评估知识,态度,障碍和促进因素:戒烟,参与 戒烟线,经由患者健康门户链接到戒烟线,以及接收患者导航, 促进MSHC患者和卫生保健提供者获得戒烟热线。 目标3:评估社区参与策略的使用,以增加UI Health Patient的使用 在Mile Square健康中心接受护理的低收入患者之间的门户网站。 目标4:测试Mile Square Health提供Mi Quit Care的可接受性、可行性和能力, 通过UI健康门户网站进行循证和多层次干预,以增加戒烟热线的参与度。 UH3:目的1:确定Mi Quit CARE与标准治疗相比在增加患者中的有效性 参与伊利诺伊州戒烟热线和随后的戒烟结果。 目的2:评价Mi Quit CARE在UI Health NHC Mile Square诊所内多个研究中心的可扩展性 网络,并将发言翻译成西班牙语。 目的3:检查Mi Quit Care对戒烟结果的成本效益, 在高危人群中的护理标准。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GERI R DONENBERG其他文献

GERI R DONENBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GERI R DONENBERG', 18)}}的其他基金

Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
Mi QUIT CARE(Mile Square QUIT 社区-访问-推荐-扩展)
  • 批准号:
    10482391
  • 财政年份:
    2020
  • 资助金额:
    $ 123.8万
  • 项目类别:
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
Mi QUIT CARE(Mile Square QUIT 社区-访问-推荐-扩展)
  • 批准号:
    10728735
  • 财政年份:
    2020
  • 资助金额:
    $ 123.8万
  • 项目类别:
Technology-based Training Tool for an Empirically- Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders
基于技术的培训工具,用于针对青少年罪犯进行实证支持的基于群体的艾滋病毒和性传播感染预防干预
  • 批准号:
    9796401
  • 财政年份:
    2019
  • 资助金额:
    $ 123.8万
  • 项目类别:
Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders
基于技术的培训工具,用于针对青少年罪犯进行实证支持的基于群体的艾滋病毒和性传播感染预防干预
  • 批准号:
    10490978
  • 财政年份:
    2019
  • 资助金额:
    $ 123.8万
  • 项目类别:
Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders
基于技术的培训工具,用于针对青少年罪犯进行实证支持的基于群体的艾滋病毒和性传播感染预防干预
  • 批准号:
    10650431
  • 财政年份:
    2019
  • 资助金额:
    $ 123.8万
  • 项目类别:
Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders
基于技术的培训工具,用于针对青少年罪犯进行实证支持的基于群体的艾滋病毒和性传播感染预防干预
  • 批准号:
    10384017
  • 财政年份:
    2019
  • 资助金额:
    $ 123.8万
  • 项目类别:
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women
南非少女和年轻妇女的多层次综合艾滋病毒预防
  • 批准号:
    10252938
  • 财政年份:
    2018
  • 资助金额:
    $ 123.8万
  • 项目类别:
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women
南非少女和年轻妇女的多层次综合艾滋病毒预防
  • 批准号:
    10620397
  • 财政年份:
    2018
  • 资助金额:
    $ 123.8万
  • 项目类别:
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women
南非少女和年轻妇女的多层次综合艾滋病毒预防
  • 批准号:
    10466893
  • 财政年份:
    2018
  • 资助金额:
    $ 123.8万
  • 项目类别:
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women
南非少女和年轻妇女的多层次综合艾滋病毒预防
  • 批准号:
    10229121
  • 财政年份:
    2018
  • 资助金额:
    $ 123.8万
  • 项目类别:

相似海外基金

A novel patient-facing mobile platform to collect and implement patient-reported outcomes and voice biomarkers in underserved adult patients with asthma
一种面向患者的新型移动平台,用于收集和实施服务不足的成年哮喘患者的患者报告结果和语音生物标志物
  • 批准号:
    10665856
  • 财政年份:
    2023
  • 资助金额:
    $ 123.8万
  • 项目类别:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
胰高血糖素样肽 1 受体激动剂治疗成人肥胖相关症状性哮喘
  • 批准号:
    10398799
  • 财政年份:
    2021
  • 资助金额:
    $ 123.8万
  • 项目类别:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
胰高血糖素样肽 1 受体激动剂治疗成人肥胖相关症状性哮喘
  • 批准号:
    10609049
  • 财政年份:
    2021
  • 资助金额:
    $ 123.8万
  • 项目类别:
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
胰高血糖素样肽 1 受体激动剂治疗成人肥胖相关症状性哮喘
  • 批准号:
    10084583
  • 财政年份:
    2021
  • 资助金额:
    $ 123.8万
  • 项目类别:
Development of nurse-led support to enhance self-management in adult-onset asthma patients
开发护士主导的支持以加强成人哮喘患者的自我管理
  • 批准号:
    20K23142
  • 财政年份:
    2020
  • 资助金额:
    $ 123.8万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
CC16 in Childhood and Resilience to Persistent Asthma into Adult Life (Supplement)
CC16 在童年和成年生活中对持续性哮喘的抵抗力(补充)
  • 批准号:
    10189106
  • 财政年份:
    2020
  • 资助金额:
    $ 123.8万
  • 项目类别:
Investigating the Social Determinant and Developmental Risk Patterns in Childhood and Adolescence Associated with Adult Asthma and Diabetes Onset
调查儿童期和青少年期与成人哮喘和糖尿病发病相关的社会决定因素和发育风险模式
  • 批准号:
    450250
  • 财政年份:
    2020
  • 资助金额:
    $ 123.8万
  • 项目类别:
    Studentship Programs
Immunometabolic phenotypes in adult severe asthma and disease progression
成人严重哮喘和疾病进展的免疫代谢表型
  • 批准号:
    10896787
  • 财政年份:
    2019
  • 资助金额:
    $ 123.8万
  • 项目类别:
Immunometabolic phenotypes in adult severe asthma and disease progression
成人严重哮喘和疾病进展的免疫代谢表型
  • 批准号:
    10022504
  • 财政年份:
    2019
  • 资助金额:
    $ 123.8万
  • 项目类别:
Immunometabolic phenotypes in adult severe asthma and disease progression
成人严重哮喘和疾病进展的免疫代谢表型
  • 批准号:
    10684256
  • 财政年份:
    2019
  • 资助金额:
    $ 123.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了